Pacira Biosciences Inc
F:82P
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
P
|
Pacira Biosciences Inc
F:82P
|
US |
|
Qube Holdings Ltd
ASX:QUB
|
AU |
|
World Precision Machinery Ltd
SGX:B49
|
CN |
|
Preformed Line Products Co
NASDAQ:PLPC
|
US |
|
Eukedos SpA
MIL:EUK
|
IT |
Wall Street
Price Targets
82P Price Targets Summary
Pacira Biosciences Inc
According to Wall Street analysts, the average 1-year price target for
82P
is 25.87 EUR
with a low forecast of 19.83 EUR and a high forecast of 34.06 EUR.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is 82P's stock price target?
Price Target
25.87
EUR
According to Wall Street analysts, the average 1-year price target for
82P
is 25.87 EUR
with a low forecast of 19.83 EUR and a high forecast of 34.06 EUR.
What is Pacira Biosciences Inc's Revenue forecast?
Projected CAGR
10%
For the last 14 years the
compound annual growth rate for
Pacira Biosciences Inc's revenue is
32%.
The projected
CAGR
for the next 3 years is
10%.
What is Pacira Biosciences Inc's Operating Income forecast?
Projected CAGR
111%
The
compound annual growth rate
of Pacira Biosciences Inc's operating income for the next 3 years is
111%.
What is Pacira Biosciences Inc's Net Income forecast?
Projected CAGR
183%
The
compound annual growth rate
of Pacira Biosciences Inc's net income for the next 3 years is
183%.
